Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium - a serial prospective cross-sectional nationwide study of residual samples. Preprint

Nav

General Info

Geography

Belgium (BEL)

Coverage type

Country

Time period covered

01/2020 - 12/2020

Data type

Scientific literature:

Cross-sectional

Keywords

Blood tests, COVID-19, Disease outbreaks

Citation

Authors

Herzog S, De Bie J, Abrams S, Wouters I, Ekinci E, Patteet L, Coppens A, De Spiegeleer S, Beutels P, Van Damme P, Hens N, Theeten H

Journal

medRxiv

Publication year

2020

Suggested citation

Herzog S, De Bie J, Abrams S, Wouters I, Ekinci E, Patteet L, Coppens A, De Spiegeleer S, Beutels P, Van Damme P, Hens N, Theeten H. Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium - a serial prospective cross-sectional nationwide study of residual samples. Preprint. medRxiv. 2020.

DOI

10.1101/2020.06.08.20125179

GHDx Entry last modified on: May 12, 2022

Header sites

Search form

Main menu

Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium - a serial prospective cross-sectional nationwide study of residual samples. Preprint

Nav